131 related articles for article (PubMed ID: 14719122)
1. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
[TBL] [Abstract][Full Text] [Related]
2. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
[TBL] [Abstract][Full Text] [Related]
3. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
[TBL] [Abstract][Full Text] [Related]
5. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
[TBL] [Abstract][Full Text] [Related]
6. p73 is up-regulated in a subset of hepatocellular carcinomas.
Herath NI; Kew MC; Whitehall VL; Walsh MD; Jass JR; Khanna KK; Young J; Powell LW; Leggett BA; Macdonald GA
Hepatology; 2000 Mar; 31(3):601-5. PubMed ID: 10706549
[TBL] [Abstract][Full Text] [Related]
7. p73, a gene related to p53, is not mutated in esophageal carcinomas.
Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK
Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409
[TBL] [Abstract][Full Text] [Related]
9. Absence of mutation of the p73 gene in astrocytic neoplasms.
Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics of breast carcinomas with allelic loss in the p73 region.
Dominguez G; Silva J; Silva JM; Garcia JM; Miralles C; Rodriguez O; Jareño E; Provencio M; España P; Bonilla F
Breast Cancer Res Treat; 2000 Sep; 63(1):17-22. PubMed ID: 11079155
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):42-4. PubMed ID: 11464902
[TBL] [Abstract][Full Text] [Related]
12. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
13. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers.
Nomoto S; Haruki N; Kondo M; Konishi H; Takahashi T; Takahashi T; Takahashi T
Cancer Res; 1998 Apr; 58(7):1380-3. PubMed ID: 9537234
[TBL] [Abstract][Full Text] [Related]
14. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype.
Yokozaki H; Shitara Y; Fujimoto J; Hiyama T; Yasui W; Tahara E
Int J Cancer; 1999 Oct; 83(2):192-6. PubMed ID: 10471526
[TBL] [Abstract][Full Text] [Related]
15. Analysis of p73 and p53 gene deletions in multiple myeloma.
Schultheis B; Krämer A; Willer A; Hegenbart U; Goldschmidt H; Hehlmann R
Leukemia; 1999 Dec; 13(12):2099-103. PubMed ID: 10602435
[TBL] [Abstract][Full Text] [Related]
16. The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3.
Tsujimoto T; Mochizuchi S; Iwadate Y; Namba H; Nagai M; Kawamoto T; Sunahara M; Yamaura A; Nakagawara A; Sakiyama S; Tagawa M
Anticancer Res; 2000; 20(4):2495-7. PubMed ID: 10953317
[TBL] [Abstract][Full Text] [Related]
17. Genomic and allelic expression status of the p73 gene in human neuroblastoma.
Barrois M; Eychenne MK; Terrier-Lacombe MJ; Duarte N; Dubourg C; Douc-Rasy S; Chompret A; Khagad M; Hartmann O; Caput D; Bénard J
Med Pediatr Oncol; 2001 Jan; 36(1):45-7. PubMed ID: 11464903
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the p73 gene in human breast cancers.
Shishikura T; Ichimiya S; Ozaki T; Nimura Y; Kageyama H; Nakamura Y; Sakiyama S; Miyauchi M; Yamamoto N; Suzuki M; Nakajima N; Nakagawara A
Int J Cancer; 1999 Jun; 84(3):321-5. PubMed ID: 10371354
[TBL] [Abstract][Full Text] [Related]
19. Infrequent somatic mutations of the p73 gene in various human cancers.
Han S; Semba S; Abe T; Makino N; Furukawa T; Fukushige S; Takahashi H; Sakurada A; Sato M; Shiiba K; Matsuno S; Nimura Y; Nakagawara A; Horii A
Eur J Surg Oncol; 1999 Apr; 25(2):194-8. PubMed ID: 10218465
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
